Milan, Italy

Gael Ronsin



 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gael Ronsin: Innovator in Ophthalmic Compounds

Introduction

Gael Ronsin is a notable inventor based in Milan, Italy. He has made significant contributions to the field of ophthalmology through his innovative work on nitric oxide donor compounds. With a total of three patents to his name, Ronsin's inventions focus on addressing critical health issues such as glaucoma and ocular hypertension.

Latest Patents

Ronsin's latest patents include "Quinone based nitric oxide donating compounds for ophthalmic use." This invention relates to nitric oxide donor compounds that possess a quinone-based structure. It outlines processes for their preparation and their application in treating and preventing glaucoma and ocular hypertension. Another significant patent is "Quinone based nitric oxide donating compounds," which also focuses on nitric oxide donor compounds with a quinone-based structure. This invention addresses pathological conditions where a deficit of nitric oxide plays a crucial role in their pathogenesis.

Career Highlights

Throughout his career, Gael Ronsin has worked with prominent companies in the pharmaceutical industry, including Nicox Science Ireland and Nicox S.A. His work has been instrumental in advancing the understanding and treatment of ocular diseases.

Collaborations

Ronsin has collaborated with several professionals in his field, including Laura Storoni and Francesca Benedini. These collaborations have contributed to the development and refinement of his innovative compounds.

Conclusion

Gael Ronsin's contributions to the field of ophthalmology through his patented inventions highlight his role as a significant innovator. His work continues to impact the treatment of ocular conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…